Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    86,147.13
    -1,622.73 (-1.85%)
     
  • CMC Crypto 200

    1,322.20
    -74.34 (-5.32%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Company News for June 3, 2020

  • Shares of Donaldson Company, Inc. DCI rose 2.3% after the company reported third-quarter fiscal 2020 earnings of 50 cents per share, surpassing the Zacks Consensus Estimate of 38 cents.

  • Shares of Tenax Therapeutics, Inc. TENX jumped 13.1% after the company reported results from Phase 2 trial of Levosimendan, which demonstrated a significant reduction in right atrial and pulmonary capillary wedge pressures.

  • Shares of Trevena, Inc. TRVN rose 3% after the company announced a collaboration agreement with Imperial College London to evaluate its TRV027 drug in coronavirus patients.

  • Shares of BioHiTech Global, Inc. BHTG soared 45.5% after the company reported that it has entered into an agreement to distribute Altapure high-level disinfectant technology that can effectively kill the coronavirus.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Donaldson Company, Inc. (DCI) : Free Stock Analysis Report
 
Trevena, Inc. (TRVN) : Free Stock Analysis Report
 
Tenax Therapeutics, Inc. (TENX) : Free Stock Analysis Report
 
Biohitech Global, Inc. (BHTG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.